Navigation Links
InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
Date:9/12/2011

BRISBANE, Calif., Sept. 12, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Esbriet® (pirfenidone) will be offered to patients in Germany beginning September 15, 2011.  This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.  Details on the launch of Esbriet in Germany will be discussed today during a conference call and webcast hosted by InterMune.

"This first launch of Esbriet is an important occasion for patients in Germany and for InterMune," said Dan Welch, Chairman, Chief Executive Officer and President of InterMune. "For the first time, German patients with IPF will have access to a medicine proven to reduce the decline in lung function, offering a treatment where none existed previously.  Our team in Germany is well staffed and trained, and fully committed to making Esbriet available to all appropriate patients as rapidly as possible and our entire organization is actively preparing to launch Esbriet throughout Europe beginning in the first half of 2012."

Conference Call and Webcast Details

InterMune will host a conference call and webcast to provide details on the launch of Esbriet in Germany, including, but not limited to information on the size and structure of the German team, the targeting of the sales force, the commercial and medical education strategy for Esbriet and the pricing of Esbriet in Germany.  The company will also provide an update on other aspects of its business beyond the German launch.

Investors, analysts and other interested parties may participate in the conference call at 8:30 a.m. EDT today by dialing 888-567-5125 (U.S.) or 706-643-9223 (international), conference I
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
2. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
3. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
4. InterMune to Present at J.P. Morgan Healthcare Conference
5. InterMune Reports Third Quarter 2010 Financial Results
6. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
7. InterMune to Release Second Quarter Financial Results on July 27
8. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
9. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
10. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
11. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... issuance of an aggregate of 30,000 stock options to ... of 120,500 stock options to employees and consultants of ... years and will be exercisable for a period of ... stock option. About Covalon Covalon Technologies ...
(Date:3/27/2015)... /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces ... grant of an aggregate of 236,070 options to certain ... the Company pursuant to the Company,s Stock Option Plan. ... the tenth anniversary of the date of grant, 5,000 ... the date of grant and 50,000 are set to ...
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies ... the field of holographic medical imaging, is entering the ... Kickstarter campaign. Launching on April 20 th , 2015, ... Voxbox Pro. The 8-inch and 22-inch displays will allow ... for the first time. In addition to the two ...
Breaking Medicine Technology:Covalon Announces Issuance of Stock Options 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3
...  ECR Booth #313/Expo C -- Varian Medical Systems, Inc. ... detectors for fluoroscopy, angiography, cardiology and cone-beam CT imaging ... in Vienna, Austria, from March 1- 5, 2012.    ... to continuous product improvement," said Stephen Kimmel, vice president ...
... SAN DIEGO, Feb. 29, 2012  Marshall Edwards, Inc. (Nasdaq: ... the clinical development of novel therapeutics targeting cancer metabolism, ... Chief Executive Officer, will present an update on Marshall ... drug candidates, ME-143 and ME-344, at the Roth Capital ...
Cached Medicine Technology:Varian Medical Systems to Exhibit X-Ray Tubes and Flat Panel Detector Technology Enhancements to Improve Digital Imaging at the ECR Annual Meeting 2Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference 2
(Date:3/27/2015)... On February 21, 2015, Choices ... Stardust Penthouse on the rooftop of the luxurious ... sustainable product TV and film placement producer, was ... which featured some of the world’s top providers ... services. , “We were honored to have a ...
(Date:3/27/2015)... While deep learning was the topic of many ... , the CEO of one start-up spoke passionately about using ... well beyond the generally-agreed ceiling of 120 years. , Insilico ... of 12 companies recognized as the hottest GPU-powered startups in ... GTC Emerging Companies Summit have business models focused on ...
(Date:3/27/2015)... LONDON, UK (PRWEB) March 27, 2015 ... SiteStart Melissa (Liss) Easy was named to the 2015 ... 40 Under 40 list spotlights 40 dynamic, up-and-coming leaders ... accomplishments and community involvement. Winners are honored at an ... supplement of the Philadelphia Business Journal. , Lyn Kremer, ...
(Date:3/27/2015)... The report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape ... and analysis of the healthcare, regulatory and reimbursement landscape ... 2013 amounted to 316.1 million, having grown at a ... The country’s increasingly elderly population and corresponding increase in ... the growth of the pharmaceutical market, which was worth ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global MEMS pressure ... MEMS based ultra-miniature pressure sensor designed especially for the ... 220um x 75um provides ample space for 1-French catheter ... industry leading in vivo drift performance of 2 ... pressure range from 0 to 1,100 mmHg absolute. ...
Breaking Medicine News(10 mins):Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:SMI Launches Catheter Mountable Pressure Sensor 2
... usual statement – often recommended by the doctors to the ... now a new study by researchers at Fox// Chase Cancer ... early-stage prostate cancer live longer if the disease is treated ... ,Researchers have found that patients (aged 65 to ...
... drinking and smoking could be damaging to health, but ... to cardiovascular diseases and// certain cancers reducing a person’s ... government medical advisor. ,Ken Snider, advisor at ... said that the problem was not only to do ...
... Research UK has suggested that certain Christmas toys are not ... 14 toys out of the 15 that// were tested, turned ... safety limits of 85 decibels. ,Among the ... included a mechanical toy machine gun, a plastic tommy gun ...
... drinking, which can be likened to about two to four ... for women, may actually be a way to live// longer. ... of death, Italian researchers have said. ,Researchers opined ... but people who already regularly consume low to moderate amounts ...
... Fetal and early childhood exposures to industrial chemicals in ... lead to neurodevelopmental disorders (NDDs)—autism,// attention deficit disorder (ADHD), ... done to identify the individual chemicals that can cause ... ,In a new review study, published in the print ...
... papers accepted for publication in the Journal of ... new patient information// provided by The Hormone Foundation, ... , Lifestyle Accelerates Testosterone Decline ... decline with age, but a new study confirms ...
Cached Medicine News:Health News:Ways to Fight Childhood Obesity 2Health News:Toy Story Turns Bitter-Christmas Toys, No Music to the Ears! 2Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 2Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 3Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 4Health News:Testosterone Decline in Men Linked to Lifestyle, Increases in Obese Girls 2
... Stereo Fundus Lens is specifically designed for ... retina. Its enhanced 3-D stereoscopic design enables ... detail, making it ideal for detecting changes ... serous detachments and other macular abnormalities. It ...
The Volk 30D is designed to provide the practitioner a wide field of view with a short working distance. This lens is excellent for use with small pupils....
The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
This excellent mid-power lens provides medium field and magnification, with an ideal diameter for grip andmanipulation in the orbital area....
Medicine Products: